Back to the main directory
Press Release
- Severina Pascu, stellvertretende CEO und Chief Consumer Officer, verlässt Sunrise by EQS Group AG
- Klenico Diagnose-Software erzielt hervorragende Validierungsergebnisse by EQS Group AG
- DSV, 1057 - SHARE BUYBACK IN DSV A/S by GlobeNewsWire
- RESULTS OF ANNUAL GENERAL MEETING 2023 by GlobeNewsWire
- Coherent Thought Leaders to Present at ECOC 2023 by GlobeNewsWire
- Radware Defends World Leading Data Center Provider and Operator from Volumetric DDoS Attacks by GlobeNewsWire
- Immunovant Announces Positive Initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results by GlobeNewsWire
- No. 17/2023 - Managers’ transactions by GlobeNewsWire
- Ault Alliance Agrees to Acquire Majority Stake in Eco Pack Technologies LTD by BusinessWire
- Verve to Present Interim Data from the heart-1 Phase 1b Clinical Trial of VERVE-101 in HeFH Patients at the American Heart Association’s Scientific Sessions 2023 by GlobeNewsWire
- DSM: Net Asset Value(s) by GlobeNewsWire
- Ferguson plc Reports Fourth Quarter and Year End Results by BusinessWire
- AN2 Therapeutics Signs Grant Agreement to Discover Novel, Boron Based Therapies for Tuberculosis and Malaria by BusinessWire
- Terrata Homes Unveils Two New Floor Plans at Southern Pines by GlobeNewsWire
- GXO Extends Partnership with VTech by GlobeNewsWire
- OTC Markets Group Welcomes Vaso Corporation to OTCQX by GlobeNewsWire
- Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation by GlobeNewsWire
- Simply Good Foods to Report Fourth Quarter and Full Fiscal Year 2023 Financial Results on Tuesday, October 24, 2023 by GlobeNewsWire
- American Lithium Makes New Lithium Discovery 6 km West of Falchani, Assays up to 2,668 ppm Lithium and over 222 metres of Mineralization – Large Lithium District Emerging by GlobeNewsWire
- Celldex Announces Acceptance of Abstract for Barzolvolimab Phase 1b Results in Prurigo Nodularis at 12th World Congress on Itch (WCI) 2023 by GlobeNewsWire
- Vigil Neuroscience Receives Positive Opinion from European Medicines Agency on Orphan Drug Designation for VGL101 for the Treatment of ALSP by GlobeNewsWire
- EQS-News: Schutzgemeinschaft der Kapitalanleger e.V.: BASF, Siemens, TUI und Co. präsentieren sich im Rahmen der SdK-Anlegerforen by EQS Group AG
- Probe Gold Awarded ECOLOGO Certification for Responsible Mineral Exploration by GlobeNewsWire
- Cynthia Romano and Chris Creger Join FTI Consulting’s Turnaround & Restructuring Practice by GlobeNewsWire
- Phillips Edison & Company Inc. Invites You to Join Its Third Quarter 2023 Earnings Conference Call by GlobeNewsWire